Novel Therapies in Diabetic Kidney Disease and Risk of Hyperkalemia: A Review of the Evidence From Clinical Trials. - Physician's Weekly


Advertisement

Novel Therapies in Diabetic Kidney Disease and Risk of Hyperkalemia: A Review of the Evidence From Clinical Trials.

Jul 31, 2023

ABOUT THE CONTRIBUTORS

  • Rehab B Albakr

    Department of Medicine, Division of Nephrology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Division of Nephrology, University of Toronto, Toronto, Ontario, Canada; Division of Nephrology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

    Vikas S Sridhar

    Division of Nephrology, University of Toronto, Toronto, Ontario, Canada; Division of Nephrology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

    David Z I Cherney

    Division of Nephrology, University of Toronto, Toronto, Ontario, Canada; Division of Nephrology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada. Electronic address: David.Cherney@uhn.ca.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

Physician’s Weekly Daily Brief

The latest articles and insights from your colleagues in your specialty(ies) of choice.